Error: Could not add to watchlist. X

Supernus Pharmaceuticals Inc

+ Watchlist
SUPN:US
NASDAQ GM
14.59
USD
0.05
0.34%
As of 17:20:00 ET on 06/03/2015.
Open
14.73
Day Range
14.44 - 14.80
Volume
798,297
Previous Close
14.54
52Wk Range
7.31 - 14.81
1 Yr Return
69.45%
Current P/E Ratio (TTM)
17.00
Earnings per Share (USD) (TTM)
0.86
Market Cap (m USD)
696.855
Shares Outstanding (m)
47.763
Price/Sales (TTM)
4.45
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma
Profile
Supernus Pharmaceuticals Inc. is a specialty pharmaceutical company. The Company develops and markets proprietary drugs for the treatment of central nervous system diseases and disorders. Supernus has developed a portfolio of clinical stage drugs to address neurological and psychological problems such as epilepsy, conduct disorder, Parkinson's disease, ADHD, depression and anxiety.
ADDRESS
1550 East Gude Drive
Rockville, MD 20850
United States
PHONE
1-301-838-2500
  • Jack A Khattar
    President/CEO/Secy/Founder
  • Stefan K F Schwabe
    Exec VP:Rsch & Dev
  • Padmanabh P Bhatt
    Senior VP:Intellectual Property
  • Victor L Vaughn
    Senior VP:Sales & Mktg
  • Gregory S Patrick
    VP/CFO/Investor Relations
Show More